Literature DB >> 22552206

Imported human rabies in a U.S. Army soldier - New York, 2011.

.   

Abstract

On August 19, 2011, a male U.S. Army soldier with progressive right arm and shoulder pain, nausea, vomiting, ataxia, anxiety, and dysphagia was admitted to an emergency department (ED) in New York for suspected rabies. Rabies virus antigens were detected in a nuchal skin biopsy, rabies virus antibodies in serum and cerebrospinal fluid (CSF), and rabies viral RNA in saliva and CSF specimens by state and CDC rabies laboratories. An Afghanistan canine rabies virus variant was identified. The patient underwent an experimental treatment protocol but died on August 31. The patient had described a dog bite while in Afghanistan. However, he had not received effective rabies postexposure prophylaxis (PEP). In total, 29 close contacts and health-care personnel (HCP) received PEP after contact with the patient. This case highlights the continued risks for rabies virus exposure during travel or deployment to rabies-enzootic countries, the need for global canine rabies elimination through vaccination, and the importance of following effective PEP protocols and ensuring global PEP availability.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22552206

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  8 in total

1.  Pre-exposure rabies vaccination among US international travelers: findings from the global TravEpiNet consortium.

Authors:  Samantha B Dolan; Emily S Jentes; Mark J Sotir; Pauline Han; Jesse D Blanton; Sowmya R Rao; Regina C LaRocque; Edward T Ryan; George M Abraham; Salvador Alvarez; Vernon Ansdell; Johnnie A Yates; Elisha H Atkins; John Cahill; Holly K Birich; Dagmar Vitek; Bradley A Connor; Roberta Dismukes; Phyllis Kozarsky; Rone Dosunmu; Jeffrey A Goad; Stefan Hagmann; DeVon Hale; Noreen A Hynes; Frederique Jacquerioz; Susan McLellan; Mark Knouse; Jennifer Lee; Regina C LaRocque; Edward T Ryan; Alawode Oladele; Hanna Demeke; Roger Pasinski; Amy E Wheeler; Sowmya R Rao; Jessica Rosen; Brian S Schwartz; William Stauffer; Patricia Walker; Joseph Vinetz
Journal:  Vector Borne Zoonotic Dis       Date:  2013-12-20       Impact factor: 2.133

2.  International travelers with infectious diseases determined by pathology results, Centers for Disease Control and Prevention - United States, 1995-2015.

Authors:  Kristina M Angelo; Kira Barbre; Wun-Ju Shieh; Phyllis E Kozarsky; Dianna M Blau; Mark J Sotir; Sherif R Zaki
Journal:  Travel Med Infect Dis       Date:  2017-10-07       Impact factor: 6.211

3.  Rabies surveillance in the United States during 2011.

Authors:  Jesse D Blanton; Jessie Dyer; Jesse McBrayer; Charles E Rupprecht
Journal:  J Am Vet Med Assoc       Date:  2012-09-15       Impact factor: 1.936

4.  Occupations at risk of contracting zoonoses of public health significance in Québec.

Authors:  Ariane Adam-Poupart; Laurie-Maude Drapeau; Sadjia Bekal; Geneviève Germain; Alejandra Irace-Cima; Marie-Pascale Sassine; Audrey Simon; Julio Soto; Karine Thivierge; France Tissot
Journal:  Can Commun Dis Rep       Date:  2021-01-29

5.  Imported human rabies cases worldwide, 1990-2012.

Authors:  Philippe Carrara; Phillipe Parola; Phillipe Brouqui; Philippe Gautret
Journal:  PLoS Negl Trop Dis       Date:  2013-05-02

6.  Emerging and re-emerging infectious diseases: challenges and opportunities for militaries.

Authors:  Zheng Jie Marc Ho; Yi Fu Jeff Hwang; Jian Ming Vernon Lee
Journal:  Mil Med Res       Date:  2014-09-24

7.  Monkey bites among U.S. military members, Afghanistan, 2011.

Authors:  Gregory A Engel; Agustin Fuentes; Benjamin P Y-H Lee; Michael A Schillaci; Lisa Jones-Engel
Journal:  Emerg Infect Dis       Date:  2013-04       Impact factor: 6.883

8.  Comparing clinical protocols for the treatment of human rabies: the Milwaukee protocol and the Brazilian protocol (Recife).

Authors:  Leandro Augusto Ledesma; Elba Regina Sampaio Lemos; Marco Aurélio Horta
Journal:  Rev Soc Bras Med Trop       Date:  2020-11-06       Impact factor: 1.581

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.